The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Serum amyloid A opposes lipoxin A 4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) will soon be the third most common cause of death globally. Despite smoking cessation, neutrophilic mucosal inflammation persistently damages the airways and fails to protect from recurrent infections. This maladaptive and excess inflammation is also refractory to glucocorticosteroids (GC). Here, we identify serum amyloid A (SAA) as a candidate mediator of GC refractory inflammation in COPD. Extrahepatic SAA was detected locally in COPD bronchoalveolar lavage fluid, which correlated with IL-8 and neutrophil elastase, consistent with neutrophil recruitment and activation. Immunohistochemistry detected SAA was in close proximity to airway epithelium, and in vitro SAA triggered release of IL-8 and other proinflammatory mediators by airway epithelial cells in an ALX/FPR2 (formyl peptide receptor 2) receptor-dependent manner. Lipoxin A 4 (LXA 4 ) can also interact with ALX/FPR2 receptors and lead to allosteric inhibition of SAA-initiated epithelial responses (pA 2 13 nM). During acute exacerbation, peripheral blood SAA levels increased dramatically and were disproportionately increased relative to LXA 4 . Human lung macrophages (CD68 + ) colocalized with SAA and GCs markedly increased SAA in vitro (THP-1, pEC 50 43 nM). To determine its direct actions, SAA was administered into murine lung, leading to induction of CXC chemokine ligand 1/2 and a neutrophilic response that was inhibited by 15-epi-LXA 4 but not dexamethasone. Taken together, these findings identify SAA as a therapeutic target for inhibition and implicate SAA as a mediator of GC-resistant lung inflammation that can overwhelm organ protective signaling by lipoxins at ALX/FPR2 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent article reported that the increase in the serum level of serum amyloid A (SAA) is associated with glucocorticoid resistance [6].”
From Picroside II Isolated from Pseudolysimachion rotundum var. subintegrum Inhibits Glucocorticoid Refractory Serum Amyloid A (SAA) Expression and SAA-induced IL-33 Secretion (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has been shown that DEX induces SAA expression on its own and synergistically increases LPS-induced SAA expression in THP-1 cells [6].”
The cited source says what the claim attributes to it.
In the citing paper
“It has been shown that SAA/IL-33 play a role in the pathology of steroid-resistant lung inflammation [6,15].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Burden and clinical features of chronic obstructive pulmonary disease (COPD)
PAUWELS, R. A., & Rabe, K. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16855-4 · Cited by 1,015
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Effects of cigarette smoke on the human airway epithelial cell transcriptome
Spira, A. E., Beane, J., Shah, V., Liu, G., Schembri, F. M., Yang, X., Palma, J. F., & Brody, J. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401422101 · Cited by 622
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 449
Su, S. B., Gong, W., Gao, J., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 430
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346
Culpitt, S. V., Rogers, D. F., Shah, P. L., de Matos, C., Russell, R. E. K., Donnelly, L., & Barnes, P. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 337
Cited by
Sorted by citations
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2015) · Nature reviews. Immunology · doi:10.1038/nri.2015.4 · Cited by 832
Self-citationSack, G. H. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0047-0 · Cited by 526
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 508
Cooray, S. N., Gobbetti, T., Montero‐Melendez, T., McArthur, S., Thompson, D., Clark, A. J. L., Flower, R. J., & Perretti, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308253110 · Cited by 301
Metadata
- Authors
- Bozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., & Anderson, G. P.
- Affiliations
- The University of Melbourne (AU)
- Brigham and Women's Hospital (US)
- Department of Pharmacology, and
- The Royal Melbourne Hospital (AU)
- John Hunter Hospital (AU)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-03
- Volume
- 109
- Issue
- 3
- Pages
- 935-940
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3271884
- OpenAlex
- W1969944763
- Cited by
- 163
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 4 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 12 · 2013: 21 · 2012: 7
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL090927, HL-68669, P50HL107166, HL090927, R01HL068669)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- serum amyloid A, lipoxin A4, chronic obstructive pulmonary disease, glucocorticoid resistance, lung inflammation, neutrophil recruitment, airway epithelial cells, interleukin-8, neutrophil elastase, acute exacerbation, lung macrophages, bronchoalveolar lavage fluid
- MeSH terms
- Serum Amyloid A Protein, Animals, Bronchoalveolar Lavage Fluid, Epithelial Cells, Epithelium, Glucocorticoids, Humans, Lung, Macrophages, Mucous Membrane, Neutrophils, Pneumonia, Interleukin-8, Neutrophil Activation, Pulmonary Disease, Chronic Obstructive, Receptors, Formyl Peptide, Lipoxins, Receptors, Lipoxin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
